Doctor profile · Federal record
Dr. Kevin Patrizio, OD
Optometrist · Corneal and Contact Management Optometrist · New York, NY
- NPI 1780200030
- 6 yrs on file
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
30 E 60Th St Rm 201
New York, NY 100221085
(212) 355-5145
Credentials & registration
- NPI registered
- June 2020 — 6 yrs on file
- Profile last updated
- December 28, 2021
- Specialty taxonomy
- 152W00000X — NUCC code
- State license (1)
- Rhode Island #ODTG00697
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1780200030. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$1,808
Transactions
58
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Bausch & Lomb Americas INC. | 15 | $716.72 | |
| Alcon Vision LLC | 6 | $345.86 | |
| Sun Pharmaceutical Industries INC. | 14 | $165.76 | |
| Johnson & Johnson Vision Care, INC. | 2 | $156.33 | |
| Tarsus Pharmaceuticals, INC. | 11 | $137.13 | |
| CooperVision INC. | 2 | $117.48 | |
| Oyster Point Pharma, INC. | 4 | $76.27 | |
| Dompe US, INC. | 2 | $53.00 | |
| Harrow Eye, LLC | 2 | $39.46 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
66
Patients
38
Total drug cost
$30,888
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tobramycin-Dexamethasone (Tobramycin/Dexamethasone) | Brand | 24 | 24 | $1,473 |
| Cequa (Cyclosporine) | Brand | 15 | 0 | $17,803 |
| Ofloxacin | Generic | 15 | 14 | $370 |
| Restasis (Cyclosporine) | Brand | 12 | 0 | $11,242 |
Frequently asked questions
What is Dr. Kevin Patrizio's medical specialty?
Dr. Kevin Patrizio practices Optometrist in New York, NY.
Where does Dr. Kevin Patrizio practice?
Dr. Kevin Patrizio practices at 30 E 60Th St Rm 201, New York, NY 100221085. Office phone: 2123555145.
What is Dr. Kevin Patrizio's NPI?
Dr. Kevin Patrizio's National Provider Identifier (NPI) is 1780200030, issued by NPPES.